Browse > Article
http://dx.doi.org/10.4014/jmb.1405.05020

Prevalence and Genotype Distribution of Human Papillomavirus in Cheonan, Korea  

Kim, Jae Kyung (Department of Laboratory Medicine, Dankook University Hospital)
Jeon, Jae-Sik (Department of Laboratory Medicine, Dankook University College of Medicine)
Lee, Chong Heon (Department of Oral Pathology, College of Dentistry, Dankook University)
Kim, Jong Wan (Department of Laboratory Medicine, Dankook University College of Medicine)
Publication Information
Journal of Microbiology and Biotechnology / v.24, no.8, 2014 , pp. 1143-1147 More about this Journal
Abstract
Human papillomavirus (HPV) infection is considered to play a critical role in the development of cervical carcinoma, which is the third most common cancer among Korean females. Here, we performed a baseline study of HPV infection and genotyping using an HPV DNA chip, which is a type of oligonucleotide microarray. A total of 6,855 cervical swab specimens from 5,494 women attending Dankook University Hospital Health Improvement Center in Cheonan, Korea between 2006 and 2012, originally collected for HPV infection screening, were genotyped for HPV. The extracted DNA from the cervical specimens was investigated by an HPV DNA chip designed to detect 41 different HPV types. HPV was identified as positive in 1,143 (16.7%) of the 6,855 samples. The most frequently detected HPV genotypes were HPV types 16, 53, 56, 58, 39, 52, 70, 84, 68, 62, 35, 54, 81, 18, and 30, in descending order of incidence. The proportions of single and multiple HPV infections in the HPV-positive specimens were 78.1% and 21.9%, respectively. The average age of HPV-positive patients was 39.9 years, with the positive rate of HPV being the highest in the 10-29 age group (20.6%). We report here on the prevalence and distribution of 41 different genotypes of HPV according to age among women in Cheonan, Korea. These data may be of use as baseline data for the assessment of public health-related issues and for the development of area-specific HPV vaccines.
Keywords
HPV DNA chip; HPV genotyping; prevalence; HPV type 58;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348: 518-527.   DOI   ScienceOn
2 Nygard M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, et al. 2014. Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance. PLoS One 9: e88323.   DOI
3 Nyitray AG, Iannacone MR. 2014. The epidemiology of human papillomaviruses. Curr. Probl. Dermatol. 45: 75-91.   DOI   ScienceOn
4 Schiffman M, Adrianza ME. 2000. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol. 44: 726-742.   DOI   ScienceOn
5 Vidal AC, Murphy SK, Hernandez BY, Vasquez B, Bartlett JA, Oneko O, et al. 2011. Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women. Infect. Agent. Cancer 6: 20.   DOI   ScienceOn
6 Seol HJ, Ki KD, Lee JM. 2014. Epidemiologic characteristics of cervical cancer in Korean women. J. Gynecol. Oncol. 25: 70-74.   DOI   ScienceOn
7 Shin E, Bae H, Song WK, Jung SK, Hwang YS. 2013. Comparative evaluation of the HPV28 detection and HPV DNA Chip Test for detecting and genotyping human papillomaviruses. Lab. Med. Online 3: 234-241.   DOI
8 Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. 2003. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int. J. Cancer 103: 413-421.   DOI   ScienceOn
9 Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. 2009. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J. Natl. Cancer Inst. 101: 475-487.   DOI   ScienceOn
10 An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, et al. 2003. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97: 1672-1680.   DOI   ScienceOn
11 Baudu A, Prétet JL, Riethmuller D, Chotard M, Mougin C, Mercier M. 2014. Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15-23 years. J. Epidemiol. Glob. Health 4: 35-43.   DOI   ScienceOn
12 Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87: 796-802.   DOI   ScienceOn
13 Chung S, Shin S, Yoon JH, Roh EY, Seoung SJ, Kim GP, et al. 2013. Prevalence and genotype of human papillomavirus infection and risk of cervical dysplasia among asymptomatic Korean women. Ann. Clin. Microbiol. 16: 87-91.   DOI
14 Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, et al. 2006. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J. Natl. Cancer Inst. 98: 303-315.   DOI   ScienceOn
15 Chen Q, Xie LX, Qing ZR, Li LJ, Luo ZY, Lin M, et al. 2012. Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China. PLoS One 7: e32149.   DOI
16 Cho NH, An HJ, Jeong JK, Kang S, Kim JW, Kim YT, et al. 2003. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am. J. Obstet. Gynecol. 188: 56-62.   DOI   ScienceOn
17 Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88: 63-73.   DOI   ScienceOn
18 De Vuyst H, Parisi MR, Karani A, Mandaliya K, Muchiri L, Vaccarella S, et al. 2010. The prevalence of human papillomavirus infection in Mombasa, Kenya. Cancer Causes Control 21: 2309-2313.   DOI   ScienceOn
19 Estrade C, Menoud PA, Nardelli-Haefliger D, Sahli R. 2011. Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes. J. Clin. Microbiol. 49: 3474-3481.   DOI   ScienceOn
20 Gargiulo F, De Francesco MA, Schreiber C, Ciravolo G, Salinaro F, Valloncini B, et al. 2007. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res. 125: 176-182.   DOI   ScienceOn
21 Hwang HS, Park M, Lee SY, Kwon KH, Pang MG. 2004. Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip. Cancer Epidemiol. Biomarkers Prev. 13: 2153-2156.
22 Kim YT. 2009. Current status of cervical cancer and HPV infection in Korea. J. Gynecol. Oncol. 20: 1-7.   DOI   ScienceOn
23 Grahovac M, Raciæ I, Hadzisejdiæ I, Doriæ A, Grahovac B. 2007. Prevalence of human papillomavirus among Croatian women attending regular gynecological visit. Coll. Antropol. 31 (Suppl 2): 73-77.
24 Grinsztejn B, Veloso VG, Levi JE, Velasque L, Luz PM, Friedman RK, et al. 2009. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. Int. J. Infect. Dis. 13: 72-80.   DOI   ScienceOn
25 Kim HW. 2012. Knowledge about human papillomavirus (HPV), and health beliefs and intention to recommend HPV vaccination for girls and boys among Korean health teachers. Vaccine 30: 5327-5334.   DOI   ScienceOn
26 Kim Y J, Kwon MJ, Woo HY, Paik SY. 2013. P revalence of human papillomavirus infection and genotype distribution determined by the cyclic-catcher melting temperature analysis in Korean medical checkup population. J. Microbiol. 51: 665-670.   DOI   ScienceOn
27 Lee GH, Kang HJ, K im SY, Park CM. 2011. The p revalence of human papilloma virus infections according to Pap smear results in Jeju island. Korean J. Obstet. Gynecol. 54: 689-695.   DOI